Artificial intelligence in the Remote Patient Monitoring Market was valued at $2.08 billion in 2024, expected to reach $14.51 billion by 2032, with a CAGR of 27.52%. The U.S. market alone was valued at $1.01 billion in 2024, projected to reach $6.84 billion by 2032 at a CAGR of 27.07%.
The shift to value-based and patient-centric care is boosting global market growth, with AI playing a crucial role in remote patient monitoring for better clinical outcomes, reduced costs, and alignment with value-based care.
Key companies profiled in the market include Koninklijke Philips N.V., Medtronic plc, GE HealthCare, Dexcom Inc., Biofourmis Inc., Tunstall Healthcare, AliveCor Inc., Biobeat, Current Health, and Dozee, along with other emerging players.
The AI-enabled devices segment held 41.8% of the market share in 2024, with the services segment expected to experience the fastest growth rate. Natural Language Processing dominated the technology segment, while the diabetes management segment led in application.
Hospitals & health systems dominated the end-use segment in 2024, with home healthcare providers anticipated to see the fastest growth. North America led the market in 2024 with a 52.5% share, while Asia Pacific is the fastest-growing region with a 28.47% share.
Recent developments include strategic partnerships between companies like Royal Philips and smartQare, and FluidAI Medical and Medtronic Canada ULC. Exclusive sections of the report include AI adoption rate metrics, patient coverage & RPM penetration index, regional investment & funding landscape, algorithm performance & technology benchmarking, and digital health infrastructure & ecosystem readiness.
The report’s scope includes market size data, CAGR projections, key segments by component, technology, application, and end-use, along with regional analysis and coverage across North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
For more information and to purchase the report, visit the link provided.
Read more at GlobeNewswire: Artificial Intelligence in Remote Patient Monitoring Market